Compare market size and growth of key Healthcare markets

Compare market size and growth of key Healthcare markets

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Loading...

Categories

28 Philippines Pharmaceuticals Reports

Philippines Diabetes Care Drugs Industry

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk

APAC Insulin Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee

Asia Pacific DPP Drugs Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: AstraZeneca, Eli Lilly and Company, Merck and Co., Novartis AG, Bristol-Myers Squibb

Asia-Pacific GLP 1 Agonist Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis, Biocon Ltd.

Diabetes Drug Market in Asia Pacific

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis

Asia Pacific SGLT2 Inhibitors Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb

APAC Biguanide Industry

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis

APAC Meglitinide Industry

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon

Asia-Pacific Alpha-Glucosidase Inhibitors Industry

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark

Asia-Pacific Oral Anti-Diabetic Drug Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Sanofi, Eli Lily, Astellas, Astrazeneca, Janssen

Insulin Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Pfizer Inc.

Diabetes Care Drugs Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company

DPP4 Drugs Industry

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Merck, AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., Pfizer Inc., Eli Lilly and Company

GLP-1 Agonists Market

Country Covered: Philippines

Study Period: 2019- 2029

Major Players: AstraZeneca, Eli Lilly and Company, Sanofi, Novo Nordisk A/S, Pfizer Inc.

Oral Antidiabetic Drugs Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals, AstraZeneca

Alpha Glucosidase Inhibitor Drugs Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Sun Pharma, Bayer, Takeda, Torrent Pharmaceuticals, Pfizer Inc.

Biguanides Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.

Diabetes Combination Drugs Market

Country Covered: Philippines

Study Period: 2019- 2029

Major Players: Boehringer Ingelheim, Sanofi Aventis, Merck & Co., Inc., Eli Lilly and Company, Novo Nordisk A/S

Meglitinides Market

Country Covered: Philippines

Study Period: 2019- 2029

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

Sulfonylureas Industry

Country Covered: Philippines

Study Period: 2019- 2029

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

SGLT2 Inhibitors Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Glargine Insulin Market

Country Covered: Philippines

Study Period: 2018 - 2029

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Wegovy Market

Country Covered: Philippines

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S

Ozempic Market

Country Covered: Philippines

Study Period: 2018-2029

Major Players: Novo Nordisk A/S

Liraglutide Market

Country Covered: Philippines

Study Period: 2018-2029

Major Players: Novo Nordisk A/S

Injectable Anti-diabetic Drugs Market

Country Covered: Philippines

Study Period: 2018-2029

Major Players: Novo Nordisk, Lilly, Julphar, Biocon, Sanofi

Trulicity Market

Country Covered: Philippines

Study Period: 2021-2029

Major Players: Eli Lilly